Supraglottic Airway Interface for Positive Pressure Ventilation During Delivery Room Resuscitation of Premature Infants: A Pilot Feasibility Trial

What this Trial Is About

Researchers are evaluating whether using a supraglottic airway (SA) as the main interface for positive pressure ventilation (PPV) is feasible during delivery room resuscitation in premature infants born between 29 0/7 and 33 6/7 weeks' gestation. The study aims to determine if this method can effectively provide ventilation immediately after birth in these infants who require resuscitation. The study involves a single group of premature infants who need PPV at birth. These infants will receive ventilation through a supraglottic airway as the primary airway interface during delivery room resuscitation. The intervention is applied immediately after birth if resuscitation is required, focusing on the placement and use of the supraglottic airway. Participants will be screened before birth with parental consent obtained, then reassessed for eligibility at delivery. Clinical and procedural data will be collected during resuscitation and for up to 24 hours after birth. Researchers will measure the feasibility of using the supraglottic airway as the primary ventilation interface within the first 10 minutes of life, along with the timing and duration of airway placement during resuscitation.

Supraglottic Airway for Resuscitation in Preemies